You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Xolair

Showing 26 - 50 of 158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allergic Disease, Chronic Spontaneous Urticaria, Chronic Inducible Urticaria Trial in Seongnam-si, Suwon-si, Seoul (YH35324,

Recruiting
  • Allergic Disease
  • +3 more
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +4 more
Jul 24, 2023

Atopic Healthy Subjects, Adult Subjects With Mild Allergic Diseases Trial in Korea, Republic of (YH35324, Placebo, Omalizumab)

Completed
  • Atopic Healthy Subjects
  • Adult Subjects With Mild Allergic Diseases
  • Suwon-si, Gyeonggi-do, Korea, Republic of
  • +3 more
Jan 26, 2023

Atopic Healthy Subjects, Adult Subjects With Mild Allergic Diseases Trial in Seongnam-si, Suwon-si, Seoul (YH35324, Placebo,

Recruiting
  • Atopic Healthy Subjects
  • Adult Subjects With Mild Allergic Diseases
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +3 more
Nov 11, 2022

Chronic Urticaria Trial in Denver (Omalizumab)

Completed
Has Results
  • Chronic Urticaria
  • Denver, Colorado
    University of Colorado Hospital
Nov 10, 2020

Aspirin Sensitivity Trial in Cleveland (Omalizumab, )

Completed
Has Results
  • Aspirin Sensitivity
  • Cleveland, Ohio
    The Cleveland Clinic
Oct 12, 2020

Bullous Pemphigoid Trial in Sacramento (Rituximab combined with Omalizumab)

Not yet recruiting
  • Bullous Pemphigoid
  • Rituximab combined with Omalizumab
  • Sacramento, California
    University of California, Davis, Department of Dermatology
Aug 16, 2021

Asthma, Allergic Rhinitis, Atopic Dermatitis Trial in Sacramento (Omalizumab, Placebo)

Completed
Has Results
  • Asthma
  • +2 more
  • Sacramento, California
    UC Davis Department of Dermatology
Jun 21, 2021

Urticaria Chronic Trial in Baltimore (Omalizumab)

Completed
Has Results
  • Urticaria Chronic
  • Baltimore, Maryland
    Johns Hopkins Asthma and Allergy Center
May 20, 2021

Milk Allergy Trial in Stanford, Baltimore, New York (Placebo for omalizumab, Omalizumab, Milk powder)

Completed
Has Results
  • Milk Allergy
  • Placebo for omalizumab
  • +2 more
  • Stanford, California
  • +2 more
Aug 12, 2020

Healthy Volunteers Trial in Moscow (Omalizumab (JSC "GENERIUM", the Russian Federation), Xolair® (Novartis Pharma AG,

Completed
  • Healthy Volunteers
  • Omalizumab (JSC "GENERIUM", the Russian Federation)
  • Xolair® (Novartis Pharma AG, Switzerland)
  • Moscow, RF, Russian Federation
  • +1 more
Oct 19, 2020

Biological Therapies for Severe Asthma.

Recruiting
  • Asthma
  • Mepolizumab
  • +4 more
  • Málaga, Spain
    Hospital Civil-Hospital Regional Universitario de Málaga
Apr 23, 2021

Hypersensitivity, Food Allergy, Hypersensitivity, Food Trial in Los Angeles, Mountain View, San Diego (Omalizumab, Dupilumab,

Recruiting
  • Hypersensitivity
  • +4 more
  • Los Angeles, California
  • +2 more
Aug 25, 2021

Symptomatic Dermographism Trial in Freiburg, Mainz (Omalizumab, Placebo)

Completed
Has Results
  • Symptomatic Dermographism
  • Freiburg, Germany
  • +1 more
Oct 9, 2020

Similarity of Pharmacokinetics and Safety Trial in Shanghai (HS632, Omalizumab (Xolair®))

Unknown status
  • Similarity of Pharmacokinetics and Safety
  • Shanghai, Shanghai, China
    Anhui Peng
Aug 20, 2020

Asthma Trial in United States (Omalizumab, Placebo)

Recruiting
  • Asthma
  • Phoenix, Arizona
  • +12 more
Jan 13, 2022

Food Allergy Trial in Baltimore, New York (Chinese Herbal Medication, Placebo, Omalizumab)

Unknown status
  • Food Allergy
  • Chinese Herbal Medication
  • +3 more
  • Baltimore, Maryland
  • +1 more
Aug 10, 2020

Asthma, Allergic Trial (omalizumab)

Not yet recruiting
  • Asthma, Allergic
  • omalizumab
  • (no location specified)
Aug 30, 2023

Increased Immunoglobulin E to Anti-herpes Simplex Virus -1

Recruiting
  • Atopic Dermatitis With a History of Eczema Herpeticum
  • +2 more
  • Xolair
  • Denver, Colorado
    National Jewish Health
Mar 4, 2021

Asthma, Eosinophilic Asthma Trial in New Lambton (Mepolizumab, Omalizumab)

Unknown status
  • Asthma
  • Eosinophilic Asthma
  • New Lambton, New South Wales, Australia
    John Hunter Hospital
Oct 6, 2020

Chronic Sinusitis Trial (Placebo, Xolair)

Withdrawn
  • Chronic Sinusitis
  • Placebo
  • Xolair
  • (no location specified)
Jan 30, 2020

Chronic Spontaneous Urticaria Trial in China (Omalizumab, Placebo)

Completed
Has Results
  • Chronic Spontaneous Urticaria
  • Beijing, Beijing, China
  • +26 more
Nov 3, 2020

Asthma Trial in New York (Omalizumab, Placebo)

Terminated
Has Results
  • Asthma
  • New York, New York
    New York University School of Medicine
Sep 25, 2019

Food Allergy Trial in Los Angeles, Mountain View (Omalizumab, Food Flour Allergens)

Completed
Has Results
  • Food Allergy
  • Los Angeles, California
  • +1 more
Apr 7, 2020

Allergy Induced Asthma Trial (omalizumab)

Withdrawn
  • Allergy Induced Asthma
  • (no location specified)
Jul 8, 2019

Chronic Rhinosinusitis With Nasal Polyps, Asthma Trial in Worldwide (Dupilumab, Omalizumab, Placebo)

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Asthma
  • Tucson, Arizona
  • +65 more
Jul 12, 2022